Investors & Media

Press Releases

Press Releases

Date Title View
Toggle Summary Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 2, 2023-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Thursday, February 16, 2023 at 8:00 a.m.
View HTML
Toggle Summary Sage Therapeutics to Provide Update on 2023 Key Initiatives at 41st Annual J.P. Morgan Healthcare Conference
Robust pipeline provides potential for long-term value creation, establishing Sage as a leader in brain health Rolling New Drug Application (NDA) submission for zuranolone in MDD and PPD complete, with potential for PDUFA date as early as the third quarter of 2023 if priority review is received and
View HTML
Toggle Summary Sage Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jan. 3, 2023-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January
View HTML
Toggle Summary Sage Therapeutics and Biogen Complete Rolling Submission of New Drug Application for Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Zuranolone is being evaluated as a short course, rapid-acting, oral medication for major depressive disorder (MDD) and postpartum depression (PPD) CAMBRIDGE, Mass. --(BUSINESS WIRE)--Dec. 6, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc.
View HTML
Toggle Summary Sage Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Nov. 23, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Piper Sandler 34 th Annual Healthcare Conference on Thursday,
View HTML
Toggle Summary Sage Therapeutics and Biogen to Host Investor Webcast on December 6, 2022 to Discuss Potential Commercialization Plans for Zuranolone
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Nov. 22, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) today announced that the companies will host a joint investor webcast to discuss the planned commercialization approach and opportunity for their investigational product,
View HTML
Toggle Summary Sage Therapeutics to Present at the Stifel 2022 Healthcare Conference
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Nov. 9, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 ,
View HTML
Toggle Summary Sage Therapeutics Announces Third Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
Completion of rolling NDA submission for zuranolone in MDD and PPD on track for December 2022 Presented additional data across pipeline programs at key medical congresses including data on zuranolone as an investigational oral, once-daily, 14-day treatment for MDD and PPD Company appoints Laura
View HTML
Toggle Summary Sage Therapeutics Appoints Laura M. Gault, M.D., Ph.D. as Chief Medical Officer
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Nov. 1, 2022-- Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced the appointment of Laura Gault , MD, Ph.D. as Chief Medical Officer. In her new role, Dr.
View HTML
Toggle Summary Sage Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Oct. 25, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 8, 2022 at 8:00 a.m.
View HTML